VGXI Blog

Welcome to the VGXI blog where we examine scientific trends, innovation, technological advancements in plasmid DNA manufacturing, and uncover how next-generation therapeutics are shaping the future of medicine and improving patients’ lives.

Five Qualities to Look for in a CDMO

As the biopharmaceutical industry increasingly turns to outsourcing, the key to success lies in choosing the right Contract Development and Manufacturing Organization (CDMO). A trusted CDMO partner can bridge the gap between research and commercialization and be your guide as your product[…]

  Read More

Stephanie Burke Named as VGXI’s New Chief Accounting Officer

Leading plasmid DNA CDMO VGXI, Inc. announces the appointment of Stephanie Burke as its new[…]

  Read More

VGXI’s Full Spectrum Plasmid DNA Solutions: From Discovery to Commercialization

Plasmids are small, circular, double-stranded DNA molecules that have become indispensable[…]

  Read More

VGXI, Inc. Names Jeff Whitmore as New Chief Commercial Officer

Leading plasmid DNA CDMO VGXI, Inc. announces the appointment of Jeff Whitmore as its new Chief[…]

  Read More

VGXI Celebrates the Grand Opening for its New Headquarters and Manufacturing Facility

With original operations based in The Woodlands, TX, industry recognized plasmid DNA contract[…]

  Read More

An Introduction to DNA and Vaccines

Vaccines are one of humanity’s most important inventions as they help protect public health[…]

  Read More

VGXI Announces Grand Opening Celebration for New Headquarters and Manufacturing Facility

Specialized plasmid DNA contract manufacturer VGXI, Inc. announces date for the Grand Opening[…]

  Read More

VGXI Celebrates First Look Event at New Manufacturing Facility

VGXI opened the doors of its new headquarters and manufacturing facility on 09Apr22 to provide[…]

  Read More

VGXI Official COVID-19 Statement

To our Valued Clients and Business Partners, VGXI’s top priority is to continue delivering[…]

  Read More

VGXI Partner IMM Announces $12M NIH Grant to Support Phase 1 Clinical Trial of a DNA Vaccine for the Prevention of Alzheimer’s Disease

Texas-based CDMO VGXI, Inc. is excited to announce that its partner, The Institute for[…]

  Read More